Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis.
Maehara T, Kaneko N, Perugino CA, Mattoo H, Kers J, Allard-Chamard H, Mahajan VS, Liu H, Murphy SJ, Ghebremichael M, Fox D, Payne AS, Lafyatis R, Stone JH, Khanna D, Pillai S. Maehara T, et al. Among authors: lafyatis r. J Clin Invest. 2020 May 1;130(5):2451-2464. doi: 10.1172/JCI131700. J Clin Invest. 2020. PMID: 31990684 Free PMC article. Clinical Trial.
Targeting fibrosis in systemic sclerosis.
Lafyatis R. Lafyatis R. Endocr Metab Immune Disord Drug Targets. 2006 Dec;6(4):395-400. doi: 10.2174/187153006779025766. Endocr Metab Immune Disord Drug Targets. 2006. PMID: 17214585 Review.
Innate immunity and inflammation in systemic sclerosis.
Lafyatis R, York M. Lafyatis R, et al. Curr Opin Rheumatol. 2009 Nov;21(6):617-22. doi: 10.1097/BOR.0b013e32832fd69e. Curr Opin Rheumatol. 2009. PMID: 19633559 Free PMC article. Review.
Cardiac arrhythmias and conduction defects in systemic sclerosis.
Vacca A, Meune C, Gordon J, Chung L, Proudman S, Assassi S, Nikpour M, Rodriguez-Reyna TS, Khanna D, Lafyatis R, Matucci-Cerinic M, Distler O, Allanore Y; Scleroderma Clinical Trial Consortium Cardiac Subcommittee. Vacca A, et al. Among authors: lafyatis r. Rheumatology (Oxford). 2014 Jul;53(7):1172-7. doi: 10.1093/rheumatology/ket377. Epub 2013 Nov 15. Rheumatology (Oxford). 2014. PMID: 24241036 Free PMC article. Review.
Editorial: Epigenetics in Systemic Sclerosis.
Lafyatis R. Lafyatis R. Arthritis Rheumatol. 2016 Dec;68(12):2841-2844. doi: 10.1002/art.39830. Arthritis Rheumatol. 2016. PMID: 27482953 No abstract available.
Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90.
Nazari B, Rice LM, Stifano G, Barron AM, Wang YM, Korndorf T, Lee J, Bhawan J, Lafyatis R, Browning JL. Nazari B, et al. Among authors: lafyatis r. Am J Pathol. 2016 Oct;186(10):2650-64. doi: 10.1016/j.ajpath.2016.06.020. Epub 2016 Aug 23. Am J Pathol. 2016. PMID: 27565038 Free PMC article.
Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic Sclerosis.
Fleury M, Belkina AC, Proctor EA, Zammitti C, Simms RW, Lauffenburger DA, Snyder-Cappione JE, Lafyatis R, Dooms H. Fleury M, et al. Among authors: lafyatis r. Arthritis Rheumatol. 2018 Apr;70(4):566-577. doi: 10.1002/art.40399. Epub 2018 Mar 7. Arthritis Rheumatol. 2018. PMID: 29245183 Free PMC article.
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
Denton CP, Ong VH, Xu S, Chen-Harris H, Modrusan Z, Lafyatis R, Khanna D, Jahreis A, Siegel J, Sornasse T. Denton CP, et al. Among authors: lafyatis r. Ann Rheum Dis. 2018 Sep;77(9):1362-1371. doi: 10.1136/annrheumdis-2018-213031. Epub 2018 May 31. Ann Rheum Dis. 2018. PMID: 29853453 Free PMC article. Clinical Trial.
248 results